# EDGAR Filing Document

**Accession Number:** 0001165320
**File Stem:** 0001437749-23-006115
**Filing Date:** 2023-3
**Character Count:** 6292
**Document Hash:** f05ad3b99169e0877ec9f25d96c9cc26
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-23-006115.hdr.sgml**: 20230310

**ACCESSION NUMBER**: 0001437749-23-006115

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20230309

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20230310

**DATE AS OF CHANGE**: 20230310

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GB SCIENCES INC
- **CENTRAL INDEX KEY:** 0001165320
- **STANDARD INDUSTRIAL CLASSIFICATION:** CRUDE PETROLEUM & NATURAL GAS [1311]
- **IRS NUMBER:** 593733133
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-55462
- **FILM NUMBER:** 23722819

**BUSINESS ADDRESS:**
- **STREET 1:** 6450 CAMERON STREET #110A
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89118
- **BUSINESS PHONE:** (844) 843-2569

**MAIL ADDRESS:**
- **STREET 1:** 6450 CAMERON STREET #110A
- **CITY:** LAS VEGAS
- **STATE:** NV
- **ZIP:** 89118

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Growblox Sciences, Inc.
- **DATE OF NAME CHANGE:** 20140603

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Signature Exploration & Production Corp.
- **DATE OF NAME CHANGE:** 20080602

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Diabetic Treatment Centers of America, Inc.
- **DATE OF NAME CHANGE:** 20040812

gblx20230309_8k.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D. C. 20549**

**FORM **8-K**

**CURRENT REPORT**

**Pursuant to Section 13 Or 15(d) of the Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported): **March 9, 2023**

**<u>GB Sciences, Inc.</u>**

(Exact name of Registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **<u>Nevada</u>**<br> (State or other Jurisdiction of<br> Incorporation or organization) | **<u>000-55462</u>**<br> (Commission File Number) | **<u>59-3733133</u>**<br> (IRS Employer I.D. No.) |

---

**<u>9205 W Russell Rd., Ste. 240</u>**

**<u>**<u>Las Vegas</u>**, **<u>Nevada</u> <u>89148</u>**</u>**

(Address of Principal Executive Offices) (Zip Code)

**<u>(**<u>866</u>**) **<u>721-0297</u>**</u>**

Registrant's telephone number, including area code)

**<u>N/A</u>**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule l 4a- l 2 under the Exchange Act (17 CFR 240. l 4a- l 2)

☐ Pre-commencement communications pursuant to Rule l 4d-2(b) under the Exchange Act (17 CFR 240. l 4d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. l 3e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| None | N/A | N/A |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 5.07 Submission of Matters to a Vote of Security Holders.**

The annual meeting of the shareholders of GB Sciences, Inc. was held on March 9, 2023. The results of the proposals voted on are indicated below:

1. The election to the Board of Directors of the following three individuals for a three-year term:

---

| | | | |
|:---|:---|:---|:---|
|  | **Votes For** | **Votes Withheld** | **Abstain** |
| John Poss | 196896858 | 8386707 | None |
| Dr. Andrea Small-Howard | 201115176 | 4168389 | None |
| Edmond DeFrank | 200704291 | 4579274 | None |

---

There were 69,840,191 broker non-votes with respect to the election of directors.

2. To approve an amendment to our articles of incorporation increasing the number of shares of stock our Board of Directors is authorized to issue from 600,000,000 shares to 950,000,000 shares (proposal approved):

Votes for: 193,533,468

Votes Against: 11,361,988

Votes Abstaining: 388,109

Broker Non-votes: 69,840,191

3. To ratify the appointment of Assurance Dimensions as our independent registered public accounting firm for the fiscal year ended March 31, 2023 (proposal ratified):

Votes for: 269,332,814

Votes Against: 2,860,771

Votes Abstaining: 2,930,171

Broker Non-votes: None

------

**SIGNATURE PAGE**

Pursuant to the requirement of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**GB Sciences, Inc.**<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a Nevada corporation | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**GB Sciences, Inc.**<br> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a Nevada corporation |
| Dated: March 9, 2023 | By: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; */s/ John Poss* |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; John Poss |
|  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chief Executive Officer |

---